Expression of survivin and its splice variants in gastric cancer

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 27, Issue 4, 2007, Pages 393-398

  Cheng, Zhengjiang ^a   Hu, Lihua ^a   Fu, Wenrong ^a   Zhang, Qin ^a   Liao, Xiaofeng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Real time PCR; Splice variants; Survivin

Indexed keywords

BIRC5 PROTEIN, HUMAN; ISOPROTEIN; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; TUMOR MARKER; INHIBITOR OF APOPTOSIS PROTEIN;

AGED; ARTICLE; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR; TUMOR CELL CULTURE;

AGED; FEMALE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; PROTEIN ISOFORMS; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; INHIBITOR OF APOPTOSIS PROTEINS;

EID: 34548531403     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-007-0411-8     Document Type: Article

References (19)

1. Ambrosini G, Adida C, Altieri D C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med, 1997,3:917-921
2. Ambrosini G, Adida C, Sirugo G et al. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem, 1998,273: 11 177-11 182
3. Altieri D C, Marchisio C. Survivin apoptosis: An interloper between cell death and cell proliferation in cancer. Lab Invest, 1999,79:1327-1333
4. Ryan B, O'Donovan N, Browne B et al. Expression of survivin and its splice variants survivin-2B and survivin-ΔEX3 in breast cancer. Br J Cancer, 2005,92,120-124
5. Mahotka C, Wenzel M, Springer E et al. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res, 1999,59:6097-6102
6. Conway E M, Pollefeyt S, Cornelissen J et al. Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions. Blood, 2000,95:1435-1442
7. Badran A, Yoshida A, Ishikawa K et al. Identification of a novel splice variant of the human anti-apoptopsis gene survivin. Biochem Biophys Res Commun, 2004, 314:902-907
8. Mirza A, McGuirk M, Hockenberry T N et al. Human survivin is negatively regulated by wild-type p53 and participate in p53-dependent apoptotic pathway. Oncogene, 2002,21:2613-2622
9. Krieg A, Mahotka C, Krieg T et al. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumor progression. Br J Cancer, 2002,86:737-743
10. Meng H, Lu C D, Mabuchi H et al. Prognostic significance and different properties of survivin splicing variants in gastric cancer. Cancer Letters, 2004, 216:147-155
11. Tellmann G. The E-Method: a highly accurate technique for gene-expression analysis. Nature Methods, 2006,3:i-ii
12. Span P N, Tjan-Heijnen V C, Heuvel J J et al. Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer? Clin Chem, 2006,52(9):1693-1700
13. Chiou S K, Moon W S, Jones M K et al. Survivin expression in the stomach: implication for mucosal integrity and protection. Biochem Biophys Res Commun, 2003,305(2):374-379
14. Caldas H, Jiang Y, Holloway M P et al. Survivin splice variants regulate the balance between proliferation and cell death. Oncogene, 2005,24:1994-2007
15. Noton E A, Colnaghi R, Tate S et al. Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis. J Biol Chem, 2006,281(2):1286-1295
16. Caldas H, Honsey L E, Altura R A. Survivin 2α: a novel Survivin splice variant expressed in human malignancies. Mol Cancer, 2005,4:11
17. Tanaka K, Iwamoto S, Gon G et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res, 2000,6:127-134
18. Rohayem J, Diestelkoetter P, Weigle B et al. Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients. Cancer Res, 2000,60:1815-1817
19. Islam A, Kageyama H, Takada N et al. High expression of survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene, 2000,19:617-623